2020
DOI: 10.1016/j.parepi.2020.e00156
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticles: New agents toward treatment of leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
32
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(38 citation statements)
references
References 81 publications
0
32
0
1
Order By: Relevance
“…Leishmaniasis is one of the most important infectious diseases in the world with 30,000 deaths annually 54 , which leads to the death by damaging macrophage cells, spleen, bone marrow, and liver. With the advancement of technology and the inadequacy of current therapeutic drugs, the application of nanostructures with unique properties and plant extracts with antimicrobial activities has recently attracted the attention of researchers 55 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Leishmaniasis is one of the most important infectious diseases in the world with 30,000 deaths annually 54 , which leads to the death by damaging macrophage cells, spleen, bone marrow, and liver. With the advancement of technology and the inadequacy of current therapeutic drugs, the application of nanostructures with unique properties and plant extracts with antimicrobial activities has recently attracted the attention of researchers 55 .…”
Section: Discussionmentioning
confidence: 99%
“…With the advancement of technology and the inadequacy of current therapeutic drugs, the application of nanostructures with unique properties and plant extracts with antimicrobial activities has recently attracted the attention of researchers 55 . Today, various nanostructures with different structures, suitable permeability, targeting properties, low toxicity, lack of resistance, high stability, and cost-effectiveness properties are widely deployed in the treatment of different diseases 54 , 56 . The transfer of amphotericin to glycine polymer-coated iron oxide nanoparticles could significantly reduce Leishmania parasite in the spleen 57 .…”
Section: Discussionmentioning
confidence: 99%
“…Silver nanoparticles (nano-Ag) represent antimicrobial agents with unique properties that improve their biocompatibility because of their high ratio of surface area to volume, no charge, and nontoxicity to humans. Some studies show that nano-Ag interacts with membrane or cell wall, DNA, and proteins of microorganisms to produce the antimicrobial effect [56].…”
Section: Nanoparticle-based Treatment For Infectious Diseasesmentioning
confidence: 99%
“…The benefits of encapsulation include increased solubility and bioavailability, protection against degradation, and the potential for modified release kinetics or targeting to specific sites in the body, thereby reducing toxicity of the compound of interest ( Banik et al., 2016 ; Barouti et al., 2017 ). This increase in bioavailability while limiting toxicity has resulted in improved safety profiles and efficacy of a multitude of anti- Leishmania compounds including liposomal AmB that is currently approved for clinical use ( Croft and Coombs, 2003 ; Nafari et al., 2020 ). Thus, it is likely that Retro-2 and SAR DHQZ analogs would greatly benefit from nanoparticle encapsulation to improve efficacy of these compounds through improved solubility and delivery.…”
Section: Introductionmentioning
confidence: 99%